Mapping Intersubunit Interactions of the Regulatory Subunit (RIalpha) in the Type I Holoenzyme of Protein Kinase A by Amide Hydrogen/deuterium Exchange Mass Spectrometry (DXMS)
Overview
Molecular Biology
Authors
Affiliations
Protein kinase A (PKA), a central locus for cAMP signaling in the cell, is composed of regulatory (R) and catalytic (C) subunits. The C-subunits are maintained in an inactive state by binding to the R-subunit dimer in a tetrameric holoenzyme complex (R(2)C(2)). PKA is activated by cAMP binding to the R-subunits which induces a conformational change leading to release of the active C-subunit. Enzymatic activity of the C-subunit is thus regulated by cAMP via the R-subunit, which toggles between cAMP and C-subunit bound states. The R-subunit is composed of a dimerization/docking (D/D) domain connected to two cAMP-binding domains (cAMP:A and cAMP:B). While crystal structures of the free C-subunit and cAMP-bound states of a deletion mutant of the R-subunit are known, there is no structure of the holoenzyme complex or of the cAMP-free state of the R-subunit. An important step in understanding the cAMP-dependent activation of PKA is to map the R-C interface and characterize the mutually exclusive interactions of the R-subunit with cAMP and C-subunit. Amide hydrogen/deuterium exchange mass spectrometry is a suitable method that has provided insights into the different states of the R-subunit in solution, thereby allowing mapping of the effects of cAMP and C-subunit on different regions of the R-subunit. Our study has localized interactions with the C-subunit to a small contiguous surface on the cAMP:A domain and the linker region. In addition, C-subunit binding causes increased amide hydrogen exchange within both cAMP-domains, suggesting that these regions become more flexible in the holoenzyme and are primed to bind cAMP. Furthermore, the difference in the protection patterns between RIalpha and the previously studied RIIbeta upon cAMP-binding suggests isoform-specific differences in cAMP-dependent regulation of PKA activity.
Gao S, Zhang W, Barrow S, Iavarone A, Klinman J J Biol Chem. 2022; 298(9):102350.
PMID: 35933011 PMC: 9483566. DOI: 10.1016/j.jbc.2022.102350.
Ramms D, Raimondi F, Arang N, Herberg F, Taylor S, Gutkind J Pharmacol Rev. 2021; 73(4):155-197.
PMID: 34663687 PMC: 11060502. DOI: 10.1124/pharmrev.120.000269.
Characterizing Endogenous Protein Complexes with Biological Mass Spectrometry.
Rogawski R, Sharon M Chem Rev. 2021; 122(8):7386-7414.
PMID: 34406752 PMC: 9052418. DOI: 10.1021/acs.chemrev.1c00217.
Sun S, Huang H, Lo Y, Chuang M, Hsu Y Sci Rep. 2021; 11(1):1090.
PMID: 33441668 PMC: 7806790. DOI: 10.1038/s41598-020-79905-8.
Gilchuk I, Bangaru S, Gilchuk P, Irving R, Kose N, Bombardi R Cell Host Microbe. 2019; 26(6):715-728.e8.
PMID: 31757769 PMC: 6941661. DOI: 10.1016/j.chom.2019.10.003.